Population
Patients with end-stage cardiac failure
Design
Review
Authors
Loading...
Affirms transplantation as standard for end-stage HF; leaves open research to reduce rejection and graft disease limiting long-term survival.
Cardiac transplantation provides definitive therapy for end-stage heart failure with 67% 5-year survival, though long-term success is limited by rejection, infection, and graft coronary disease.
Yeatman et al. (1995) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: